Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1

Conditions

Hodgkin Disease 48Recurrence 13Lymphoma 12Lymphoma, T-Cell, Cutaneous 10Lymphoma, T-Cell, Peripheral 9Mycosis Fungoides 8Lymphoma, T-Cell 7Lymphoma, Large-Cell, Anaplastic 7Sezary Syndrome 5Lymphoma, Non-Hodgkin 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Large B-Cell, Diffuse 4Immunoblastic Lymphadenopathy 4Enteropathy-Associated T-Cell Lymphoma 4Neoplasms, Germ Cell and Embryonal 3Lymphomatoid Papulosis 3Lymphoma, Follicular 3Leukemia, Myeloid, Acute 3Leukemia 3Testicular Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Lymphoma, Primary Cutaneous Anaplastic Large Cell 2Lymphoma, Extranodal NK-T-Cell 2Lymphoma, B-Cell, Marginal Zone 2Lymphatic Diseases 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Large Granular Lymphocytic 2Hematologic Neoplasms 2Carcinoma, Embryonal 2

Interventions

Bendamustine Hydrochloride 3fludarabine 2Cyclophosphamide 2Brentuximab Vedotin 2pembrolizumab 1ibritumomab tiuxetan 1fludarabine phosphate 1Standard of Care 1Rituximab 1Radiotherapy 1Melphalan 1Etoposide 1Cytarabine 1Carmustine 1Bone Marrow Transplantation 1AP 1903 reagent 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Lymphatic Diseases × Brentuximab Vedotin × Clear all
NCT03264131 2025-02-10

BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma

UNC Lineberger Comprehensive Cancer Center

Phase 2 Active not recruiting
16 enrolled 8 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphatic Diseases, Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT02499627 2021-05-27

FIL-BBV

Fondazione Italiana Linfomi - ETS

Phase 2 Terminated
43 enrolled
Lymphoid

Lymphatic Diseases, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡